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Abstract 
Background: To humanize yeast N‑glycosylation pathways, genes involved in yeast specific hyper‑mannosylation 
must be disrupted followed by the introduction of genes catalyzing the synthesis, transport, and addition of human 
sugars. However, deletion of these genes, for instance, OCH1, which initiates hyper‑mannosylation, could cause severe 
defects in cell growth, morphogenesis and response to environmental challenges.
Results: In this study, overexpression of RHO1, which encodes the Rho1p small GTPase, is confirmed to partially 
recover the growth defect of Saccharomyces cerevisiae Δalg3Δoch1 double mutant strain. In addition, transmission 
electron micrographs indicated that the cell wall structure of RHO1‑expressed cells have an enhanced glucan layer 
and also a recovered mannoprotein layer, revealing the effect of Rho1p GTPase on cell wall biosynthesis. Similar com‑
plementation phenotypes have been confirmed by overexpression of the gene that encodes Fks2 protein, a catalytic 
subunit of a 1,3‑β‑glucan synthase. Besides the recovery of cell wall structure, the RHO1‑overexpressed Δalg3Δoch1 
strain also showed improved abilities in temperature tolerance, osmotic potential and drug sensitivity, which were not 
observed in the Δalg3Δoch1‑FKS2 cells. Moreover, RHO1 overexpression could also increase N‑glycan site occupancy 
and the amount of secreted glycoproteins.
Conclusions: Overexpression of RHO1 in ‘humanized’ glycoprotein producing yeasts could significantly facilitate its 
future industrial applications for the production of therapeutic glycoproteins.
Keywords: Humanized N‑glycosylation, Recombinant‑protein production, Rho1p GTPase, Cell wall integrity, 
Saccharomyces cerevisiae
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Background
Therapeutic proteins have been widely used in inflamma-
tory diseases, cancer, neurological disorders and diabe-
tes [1]. A majority of therapeutic proteins display one or 
more post-translational modifications, which invariably 
influence the biochemical and therapeutic properties of 
these proteins. About 70  % of therapeutic proteins are 
glycoproteins [2] and their glycan parts have numerous 
structural, functional and regulatory roles [3]. Glycosyla-
tion can influence a variety of physiological processes, 
including intracellular targeting, protein–protein bind-
ing and molecular stability [4]. There are five types of gly-
cosylation, N-, O-, P-, C-, and G-linked [5]. All of them 
involve the addition of an oligosaccharide structure to 
the protein core but through different binding sites. 
N-Glycosylation is one of the most prevalent but struc-
turally most complex chemical modifications that occurs 
naturally in proteins.
Most therapeutic glycoproteins are currently produced 
by mammalian cells. Chinese hamster ovary (CHO) cells 
are the most commonly used higher eukaryotic cells for 
the production of glycoproteins [6]. However, due to lim-
ited growth rate, expensive serum-based media, and the 
potential spread of infectious diseases, production of gly-
coproteins in CHO cells results in low productivity and 
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an economically harsh process. Relative to mammalian 
cell culture, yeasts offer generally high yields of recom-
binant proteins, are well-characterized, give serum-free 
growth media, are readily adapted to large-scale fer-
mentation processes and have greatly reduced costs [7]. 
Humanized glycoproteins have already been produced 
in a variety of yeasts, such as Saccharomyces cerevi-
siae [8], Pichia pastoris [9, 10], Yarrowia lipolytica [11], 
Hansenula polymorpha [12], Schizosaccharomyces pombe 
[13] and Ogataea minuta [14, 15].
Although human and yeast cells share the initial stages 
of the N-glycosylation pathway in the endoplasmic 
reticulum (ER), further modification in the Golgi appa-
ratus is highly different. The final glyco-form of human 
N-glycans are mainly of the complex or hybrid type [7]. 
In contrast, yeast cells provide a yeast specific hyper-
mannosylated type N-glycosylation on recombinant gly-
coproteins, which are antigenic in humans. If these are 
used for the therapeutic purpose, such glycoproteins will 
be cleared rapidly from the bloodstream due to inter-
action with human mannose receptors, and could also 
cause immunogenic reactions in humans [16]. To mimic 
the human type of glycosylation, yeast cells have been 
glyco-engineered by disruption of genes encoding spe-
cific mannosyltransferases (e.g. ALG3 and OCH1) caus-
ing a loss of hyper-mannosylated structures followed by 
the expression of exogenous genes catalyzing the syn-
thesis, transport, and modification of human sugars [16]. 
However, the Δalg3 mutation causes under-occupancy 
of N-glycosylation sites [17]. Moreover, deletion of genes 
that encode specific glycosyltransferases, like OCH1, 
causes hypo-glycosylation of yeast cell proteins that leads 
to a direct rearrangement of cell wall constituents [18]. 
Fungal cell wall integrity plays an important role in cell 
growth and survival from various environmental stresses 
[19], thus its damage reveals a severe growth defect and a 
decrease in protein production [20, 21]. During the past 
decade, considerable efforts have been made to overcome 
this serious drawback [22]. However, the fragility of the 
cell wall in the humanized yeast cell is still the bottleneck 
of this technology.
Cell wall biogenesis in yeast is regulated by the cell wall 
integrity signaling pathway. Rho1p is considered to be 
the master regulator of the cell wall integrity pathway. In 
response to environmental challenges, the Rho1p GTPase 
mobilizes and coordinates physiological actions through 
a variety of outputs to maintain cell wall integrity [23], 
however, the effect of Rho1p in glyco-engineered yeast 
has not yet been discussed in detail. This manuscript 
describes the strategy of RHO1 overexpressing to regu-
late the cell wall integrity pathway in Δalg3Δoch1 double 
mutant S. cerevisiae cells, and increase the strength of 
cell wall to improve growth phenotype and N-glycosyla-
tion site occupancy.
Results
Overexpression of RHO1 partially recovers the growth 
defect of a glycosylation mutant strain
Cell growth is enhanced by overexpression of RHO1
In order to test the effects of overexpression of RHO1 
and FSK2 genes, plasmids blank pY26, pY26-RHO1 
and pY26-FKS2 were transformed in a wild type strain 
W303A or a glycosylation mutant Δalg3Δoch1 strain, 
respectively. The growth phenotype of these S. cerevi-
siae mutants were measured both in liquid and solid 
culture. The results were summarized in Fig.  1. The 
Δalg3Δoch1-pY26 strain showed severe growth retar-
dation (Fig.  1a, b) and increased flocculation (Fig.  1c). 
Overexpression of RHO1 could partially recover cell 
growth deficiency and decrease cell flocculation in 
Δalg3Δoch1, although it caused severe cell growth defi-
ciency in wild-type W303A. The results showed that 
Δalg3Δoch1-RHO1 were grown to logarithmic phase 
at 17 h comparing to that of W303A-pY26 at 9 h, while 
Δalg3Δoch1-pY26 exhibited a prolonged lag phase of 
26 h. Δalg3Δoch1-RHO1 and W303A-pY26 entered sta-
tionary phase at 34  h, compared to Δalg3Δoch1-pY26 
which entered the stationary phase at 58  h. The maxi-
mum OD 660 of W303A-pY26, Δalg3Δoch1-RHO1 
and Δalg3Δoch1-pY26 were 14.8  ±  0.6, 4.7  ±  0.3 and 
4.4 ±  0.2, respectively. These results suggested that the 
overexpression of RHO1 could enhance the growth per-
formance of Δalg3Δoch1-pY26, although no significant 
improvement was observed in stationary phase cell 
number. However, W303A-RHO1 showed severe growth 
defects, which might cause by morphological abnor-
malities when RHO1 was overexpressed in normal cells. 
Besides, FKS2 expressed in Δalg3Δoch1 also prevailed 
over the growth phenotype, though the results were not 
as good as RHO1.
The och1Δalg3Δ‑RHO1 strain is dispersed in liquid media
It has been previously reported that the S. cerevisiae 
OCH1 gene is a key enzyme involved in outer chain 
elongation, and its disruption leads to temperature sen-
sitivity, drug sensitivity, growth retardation, cell wall 
defects and cell aggregation [24, 25]. Our results were in 
agreement with the above reports, the och1Δalg3Δ-pY26 
double mutant strain exhibited serious cell flocculation 
(Fig. 1d). However, och1Δalg3Δ-RHO1 and -FKS2 strains 
could be dispersed in the culture broth. In addition, 
yeast cells carrying plasmids of pY26-RHO1 or pY26-
FKS2 were enlarged and more round than W303A-pY26 
(Fig. 1d).
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Fig. 1 Growth phenotype of S. cerevisiae Δalg3Δoch1 was improved by RHO1 overexpression. a S. cerevisiae mutant strains were prespread on SD‑U 
(lacking uracil) solid medium at 30 °C for 48 h before single colonies were selected and streaked on SD‑U plates for 24 h. b Growth curve of W303A‑
pY26 (solid diamonds), W303A‑FKS2 (solid round), W303A‑RHO1 (snowflake), Δalg3Δoch1‑pY26 (solid squares), Δalg3Δoch1‑FKS2 (solid triangle), and 
Δalg3Δoch1‑RHO1 (open squares). Cells were incubated in 5 ml of SD‑U liquid medium for 24 h, and then the same amount of cells were collected 
and transferred into fresh 50 ml of SD‑U medium for 66 h (30 °C, 230 rpm). c Yeast cells were cultivated in 5 ml of SD‑U liquid medium for 48 h 
(30 °C, 230 rpm) and kept horizontally for 10 min before taking photos. d Morphology of mutant cells by microscope observation. Yeast Cells were 
incubated in 5 ml of SD‑U liquid medium for 1 day (30 °C, 230 rpm). Cell morphology was determined by microscopy as described in the “Methods” 
section
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Effects of RHO1 overexpression on cell wall structure
RHO1 overexpression improves both the glycan 
and mannoprotein layer thickness
To confirm whether RHO1 or FKS2 overexpression 
affects cell wall structure, the cell wall of S. cerevisiae 
strains were directly observed by TEM analysis. Micro-
graphs were taken and the thicknesses of the cell walls as 
well as those of the mannoprotein and glucan layers were 
shown in Fig.  2. Cell wall analysis of Δalg3Δoch1-pY26 
demonstrated an increase in glucan layer thickness in 
comparison with W303A-pY26, although the manno-
protein layer was much thinner due to the deletion of 
OCH1, which initiates heavy mannose glycosylation 
in yeasts. In the micrograph of RHO1 or FKS2 overex-
pression strains, an even thicker glucan layer is visible 
compared with W303A-pY26 and Δalg3Δoch1-pY26, 
respectively. Surprisingly, an increase in mannoprotein 
layer thickness is also evident in the Rho1p overexpres-
sion strain compared to Δalg3Δoch1-pY26, which might 
be influenced by protein glycosylation as well. In conclu-
sion, TEM results suggest that the cell wall components 
could be rearranged by endogenous overexpression of 
Rho1p.
Enhanced glycan layer partially recovers the growth defect
To explore the function of Rho1p and Fks2p on 
β-glucan accumulation, the amount of β-glucan in these 
mutant cells were measured. The relative content of 
β-glucan was defined to be 100 ±  2.2 % in the cell wall 
of W303A-pY26, thus Δalg3Δoch1-pY26 was calculated 
to contain 110.5 ±  5.7  % β-glucan (Fig.  3). Overexpres-
sion of RHO1 in W303A and Δalg3Δoch1 increased the 
relative β-glucan content by 54.2 ± 0.7 and 41.9 ± 0.7 %, 
respectively. These results well corresponded to that of 
the above mentioned microscopic results. Rho1p is an 
essential component of the 1,3-β-glucan synthase com-
plex (GS complex) [26], thus it was not surprising that 
RHO1 overexpression could enhanced the glucan content 
of yeast cells. Meanwhile, the FKS2 gene which encodes 
another component of GS complex was also overex-
pressed in this study, the results showed that the β-glucan 
content was increased by 26.5 ± 3.1 % in W303A-FKS2 
and 29.6 ± 1.8 % in Δalg3Δoch1-FKS2, respectively, sug-
gesting that the thickening of the glucan layer was due to 
the activity of yeast GS complex.
To examine the extent of RHO1 and FKS2 expression 
in recombinant strains, the relative expression changes of 
RHO1 and FKS2 were determined by quantitative real-
time RT-PCR. As shown in Table  1, RHO1 in W303A-
RHO1 and Δalg3Δoch1-RHO1 strains were up-regulated 
72.0 and 6.4-fold differential expression respectively, 
comparing with W303A-pY26, and the observed signifi-
cant increase in expression can be attributed to RHO1 
overexpression. In addition, a moderate increase of FKS2 
expression was also observed in FKS2-overexpression 
strains. However, it should be noted that the och1 and 
alg3 double mutant also lead to moderate increase in 
transcriptional levels of RHO1 and FKS2 genes.
Fig. 2 Cell wall structure were optimized by RHO1 overexpression. TEM photographs of S. cerevisiae mutant strains. Cells were cultured in 5 ml of 
SD‑U liquid medium for 1 day (30 °C, 230 rpm). Cell samples were fixed in glutaraldehyde solution as described in the “Methods” section
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Effects of RHO1 overexpression on cell wall integrity
To analyse the phenotypes caused by Rho1p or Fks2p 
expressing, a series of RHO1 or FKS2 overexpres-
sion strains were subjected to multiple environmental 
stresses, such as temperature tolerance, osmotic stress 
and hygromycin B sensitivity (Fig.  4a–c). The RHO1-
overexpressing cells exhibited a significant growth recov-
ery when subjected to the above environmental stress, 
compared to Δalg3Δoch1-pY26. However, Δalg3Δoch1-
FKS2 showed more stress sensitivity than Δalg3Δoch1-
RHO1. Thus it can be supposed from our results that 
as cell wall integrity signaling is induced in response to 
a variety of cell wall stresses, the overexpression of the 
gene that encodes Rho1p GTPase which triggers the cell 
wall integrity pathway might mobilize and coordinate 
physiological actions to resist environmental challenges.
Effects of RHO1 overexpression on production 
of glycoprotein
Improvement of N‑glycan site occupancy by Rho1p 
overproduction
Disruption of the ALG3 gene results in the modification 
of proteins mainly with Man5GlcNAc2, which causes 
under-occupancy of glycosylation sites [27]. However, an 
increase in mannoprotein layer thickness in Δalg3Δoch1-
RHO1 was detected by TEM analysis (Fig. 2). To analyze 
whether RHO1 overexpression affected the glycosyla-
tion levels, western blotting assays were performed. The 
mobility pattern of carboxypeptidase Y (CPY) carrying 
four N-glycosylation sites was analysed in this work as 
a model glycoprotein. In W303A-pY26 and W303A-
RHO1, CPY was full glycosylated, thus only one band 
was shown by western blotting, respectively. Compared 
to Δalg3Δoch1-pY26, Δalg3Δoch1-RHO1 strain showed 
increased N-glycan occupancy of CPY. One to two 
N-glycosylation sites were detected in Δalg3Δoch1-pY26 
(Fig.  5a), indicating low glycosylation efficiency, which 
normally occurs in glycosylation deficient mutants [28]. 
However, in the case of the Rho1p overproduction strain, 
it apparently generates one to three occupancy sites of 
CPY at N-glycosylation sites (Additional file 1: Figure S1).
Furthermore, the structure of the N-glycans in cell 
wall mannoprotein were analyzed, using a HPLC-based 
method. The oligosaccharides from Δalg3Δoch1 and 
Δalg3Δoch1-pY26 revealed several peaks correspond-
ing to Man5GlcNAc2, Man6GlcNAc2 and Man7GlcNAc2. 
Moreover, the oligosaccharides from Δalg3Δoch1-RHO1 
did not reveal a glycoform that was different from 
the above two strains, but merely exhibited enhanced 
amounts of glycans (Fig. 5a, b). These results suggest that 
RHO1 overexpression affects the efficiency of glycosyla-
tion, which is mainly due to the attachment of shorter 
oligosaccharides but has no impact on the pattern of the 
glycan chains.
RHO1 overexpression altered protein secretion
The ability of the Δalg3Δoch1-RHO1 strain to secrete 
human lysozyme (hLYZ) as a measurement of glycopro-
tein product was analyzed thereafter. Wild type human 
lysozyme is a non-glycosylated protein, in this work one 
N-glycosylation site was introduced by site-directed 
mutagenesis. The glycosylated lysozyme illustrated a 
higher molecular weight band, and as demonstrated 
by Western blot analysis (Fig.  6a), Δalg3Δoch1-RHO1 
Fig. 3 The amount of β‑glucan was increased by RHO1 overexpres‑
sion. Relative β‑glucan content in S. cerevisiae. 5 ml of yeast cells 
were incubated in SD‑U medium for 48 h, and then transferred into 
fresh SD‑U medium for 24 h (30 °C, 230 rpm). 2.5 × 106 cells were 
harvested and quantity of β‑glucan was determined as described in 
the “Methods” section
Table 1 Differential expression of RHO1 and FKS2 in S. cer-
evisiae mutant strains
a Yeast cells were pre-cultured for 48 h and transferred to fresh SD-U medium 
for 24 h (30 °C, 230 rpm)
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secreted much more glycosylated lysozyme than both 
Δalg3Δoch1 and Δalg3Δoch1-pY26. In Δalg3Δoch1-
RHO1, 75.6  % of human lysozyme was glycosylated, 
compared to 55.1  % in Δalg3Δoch1 and 54.0  % in 
Δalg3Δoch1-pY26 (Fig.  6b). The ratios of lysozyme in 
Δalg3Δoch1, Δalg3Δoch1-pY26 and Δalg3Δoch1-RHO1 
were 1:1:1.2, suggesting Rho1p positively influenced 
secretion of foreign glycoproteins. Based on these results, 
along with the glycosylation occupancy experiments and 
cell wall structure micrographs, we can be concluded 
that the overexpression of RHO1 in och1Δalg3Δ, not only 
could improve the cell growth, but also could enhance 
the N-glycan occupancy and the secretion ability of 
glycoproteins.
Discussion
With the increasing importance for production of 
humanized glycans for therapeutic purposes, construct-
ing a suitable expression system is necessary. Upon dis-
ruption of OCH1, a loss of hyper-mannosylated structure 
in secreted glycoproteins was observed [29], leading to a 
defective mannoprotein layer in the Δalg3Δoch1 cell wall. 
The fungal cell wall, which comprises 20–30 % of cell dry 
weight, is mainly composed of 1,3-β-glucan, 1,6-β-glucan, 
mannoproteins and chitin [18]. In this study, overexpres-
sion of RHO1 has been proposed as a novel strategy to 
compensate for mannoprotein layer defects. Rho1p reg-
ulates both 1,3-β-glucan synthase encoded by the FKS1 
and FKS2 genes and the 1,6-β-glucan synthase [23]. As a 
Fig. 4 Assay results for sensitivities to different stress. a–c Resistance of W303A‑pY26, W303A‑RHO1, W303A‑FKS2, Δalg3Δoch1‑pY26, Δalg3Δoch1‑
RHO1 and Δalg3Δoch1‑FKS2 to different temperature, sorbitol content and hygromycin B content. Cells were pre‑incubated in SD‑U liquid medium 
for 1 day (30 °C, 230 rpm). Serial dilutions (1/10 each time) of each culture were spotted onto SD‑U plates and incubated with different stress 
reagents or temperature for another 48 h
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result, overexpression of RHO1 in Δalg3Δoch1 improved 
the amount of glucan and the glucan layer thickness 
of the cell wall, which partially recovered the cell wall 
defect. Similar phenomenon have been described previ-
ously in S. pombe, the cell wall tends to be thicker than 
wild-type cells when RHO1 is overexpressed [30]. Inter-
estingly, cell aggregation of glycosylation defective cells 
was also alleviated by the direct function of Rho1p in the 
cell wall, suggesting that an enhancement of glucan layer 
could partially strengthen the yeast cell wall.
As an Δalg3Δoch1-RHO1 strain is planned to be fur-
ther reconstructed and engineered for industrial use, the 
cell growth rate is considered to be an extremely impor-
tant parameter for further application. RHO1 overexpres-
sion enhanced the growth phenotype of Δalg3Δoch1 by 
both reducing the time course of log phase and improv-
ing the cell growth rate. In addition, when subjected to 
thermal, osmotic or drug stress, the growth phenotype 
was also improved by RHO1 overexpression. Contrarily, 
by overexpression of FKS2, which encodes a catalytic 
subunit of a 1,3-β-glucan synthase, no significant growth 
enhancement was detected upon extreme environmental 
stress, although the cell growth of Δalg3Δoch1-FKS2 was 
improved both in liquid and solid media under normal 
condition. As both RHO1 and FKS2 overexpression led 
to glucan accumulation in the cell wall, the reason why 
the stress resistance of Δalg3Δoch1-RHO1 was increased 
could not be simply explained by the partial recovery of 
the cell wall. Studies have shown that Rho1p is an essen-
tial protein which controls cell wall integrity signaling 
and linear series of protein kinases, known as the MAP 
kinase cascade, is responsible for amplification of the 
cell wall integrity signal from Rho1p [31]. When yeast 
cells with weakened cell walls suffer external stress, they 
commonly activate the cell wall integrity pathway [18] 
which was strengthened by RHO1 overexpression, thus 
leading to an obvious stress resistance enhancement of 
Δalg3Δoch1-RHO1. For industrial strains, easily suffered 
with a variety of different stresses from culture media, 
the stress-resistance ability in Δalg3Δoch1-RHO1 would 
be a considerable advantage in its industrial use.
Upon disruption of the ALG3 gene in yeasts, the 
reduced occupancy of N-glycosylation sites was observed 
[12]. However, consistent and robust N-glycan site occu-
pancy is desirable for the production of therapeutic gly-
coproteins in order to maintain desired product profiles. 
N-glycan site occupancy of glycoproteins is affected by 
the dolichol biosynthetic pathway, oligosaccharyltrans-
ferase complex, the target polypeptide sequence, and 
structure of oligosaccharides [10, 32]. De Pourcq et  al. 
overexpressed ALG6 in a Y. lipolytica Δalg3 strain to 
modify the target oligosaccharides structure and enhance 
site occupancy [27]. Here, an alternative method is pro-
vided to remedy under-occupancy in CPY by overex-
pression of the RHO1 gene. Based on previous reports 
that oligosaccharyltransferase may be subject to regula-
tion by the cell wall integrity pathway via an interaction 
between Pkc1p with Stt3p [18] and Rho1p interacts with 
Pkc1p by two-hybrid analyses in S. cerevisiae [33], it is 
predicted that Rho1p might indirectly regulate the activ-
ity of oligosaccharyltransferase to induce the N-glycan 
occupancy of glycoproteins. Besides, Rho1p regulates the 
1,6-β-glucan synthase which has not yet been described 
at the molecular level [23], and 1,6-β-glucan possesses 
the function to anchor mannoproteins to other cell wall 
components [34]. It was considered that RHO1 overex-
pression might activate the production of 1,6-β-glucan, 
and increase mannoprotein attachment as a result. This 
Fig. 5 Comparative analysis of glycosylation occupancy and glycan 
patterns of W303A‑pY26, W303A‑RHO1, Δalg3Δoch1‑pY26 and 
Δalg3Δoch1‑RHO1. a Analysis of glycosylation occupancy of CPY 
proteins. 5 ml of yeast cells were incubated in SD‑U medium for 
48 h, and then transferred into fresh SD‑U medium for another 24 h 
(30 °C, 230 rpm). 5 ml of growing cells were harvested and washed 
twice with deionized water. Intracellular proteins were extracted and 
analyzed by western blotting with anti‑ScCPY antibody as described 
in the “Methods” section. The number of N‑glycosylation sites is indi‑
cated by ‘n’. b Analysis of N‑glycan profiles by HPLC. Δalg3Δoch1‑pY26 
(dotted line), Δalg3Δoch1‑RHO1 (line segment), and Δalg3Δoch1 (solid 
line) were cultured in 5 ml of SD‑U liquid medium at 30 °C for 48 h, 
and then transferred to fresh 50 ml of SD‑U medium for 24 h. N‑gly‑
cans were extracted from 5 ml of each culture. Three peaks represent 
Man5GlcNAc2, Man6GlcNAc2 and Man7GlcNAc2, respectively
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speculation might be verified by the cell wall morphology 
of Δalg3Δoch1-RHO1 cells which were partially restored 
to that of W303a-pY26 with an increasing thickness in 
mannoprotein layer when compared to Δalg3Δoch1.
In addition, S. cerevisiae Δalg3Δoch1 with RHO1 over-
expression secreted more exogenous proteins. Rho1p has 
been proposed to be responsible for the spatial regula-
tion of the exocyst complex [31]. The exocyst mediates 
polarized targeting and tethering of post-Golgi secretory 
vesicles to sites of exocytosis prior to SNARE-mediated 
fusion [35]. Thus, it is possible that the exocyst complex 
was activated by RHO1 overexpression to mediate more 
secreted glycoproteins to the cell surface. The results 
presented here provide a comprehensive and convenient 
strategy to combine improved cell growth, stress resist-
ance, N-glycan site occupancy and secretion of foreign 
proteins in glycosylation defect strains. The authors 
believe that it may significantly facilitate its industrial 
applications and could be extended to other yeast expres-
sion systems as well.
Conclusions
In summary, RHO1 was overexpressed in Δalg3Δoch1 
in this study to improve the amount of cell wall content 
of glucan, thus further enhanced the cell growth pheno-
type and stress resistance. Moreover, overexpression of 
RHO1 increased N-glycan site occupancy on vacuolar 
carboxypeptidase Y protein, as judged by its mobility pat-
tern and also the amount of secreted glycoproteins in the 
medium. To the best of our knowledge, this study reports 
for the first time to enhance the cell growth, N-glycan 
occupancy and secretion ability simultaneously by simply 
overexpressing of RHO1 in S. cerevisiae.
Methods
Plasmids, strains and culturing conditions
The plasmids and yeast strains used in this study are 
described in Table  2. Standard genetic techniques were 
used unless otherwise noted [36]. Saccharomyces cerevi-
siae strain W303-1A was used as the host. Saccharomyces 
cerevisiae W303-1A genome DNA was used for ampli-
fying the RHO1 and FKS2 sequences. pY26-RHO1 and 
pY26-FKS2 were used to express RHO1 or FKS2 under 
control of the GPD1 promoter, respectively. pY26-RHO1, 
pY26-FKS2 and blank pY26 [37] were transformed into 
Δalg3Δoch1 strain, designated as Δalg3Δoch1-RHO1, 
Δalg3Δoch1-FKS2 and Δalg3Δoch1-pY26, respectively.
pRS424TEF-LYZ(R59S) [38] was used to express a 
mutated human lysosome (hLYZ), in which 59th Arg of 
hLYZ is mutated to Ser, under the control of TEF1 pro-
moter. To construct this, first, site-directed mutagenesis 
on hLYZ was performed by using QuikChange™ site-
directed mutagenesis kit (Stratagene, La Jolla, California). 
The Asn57-Thr58-Arg59 polypeptide segment was mutated 
Fig. 6 Secreted and N‑glycosylated human lysozyme was increased by RHO1 overexpression. a Analysis of human lysozyme secretion by western 
blotting. 5 ml of cells were cultured in SD‑UT (lacking uracil and tryptophan) liquid medium for 48 h and transferred into 50 mL fresh SD‑UT (30 °C, 
230 rpm) for 24 h. The secreted human lysozyme was collected from 30 ml of each supernatant and concentrated as described in the “Methods” 
section. The concentrated supernatant was analyzed by Western blotting with anti‑FLAG antibody. 2Δ: Δalg3Δoch1. b Analysis of the relative con‑
tent of human lysozyme. The ratios of human lysozyme were calculated by ImageQuant™ Software version 7.0. The relative content of lysozyme in 
the lane of Δalg3Δoch1‑LYZ was defined to be 1 ± 0.03. White glycosylated human lysozyme; Grey non‑glycosylated human lysozyme
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into Asn57-Thr58-Ser59 and Asn57 (57th amino acid of 
human lysosome) was able to be N-glycosylated. All plas-
mids constructed in this experiment have been verified 
by Sanger sequencing (Sangon, Shanghai, China). Plas-
mid maps and primer sequences are available on request.
Synthetic dropout medium (SD, 0.67 % yeast nitrogen 
base, 2 % glucose) media with appropriate supplemental 
amino acids were used to culture yeast cells and to select 
yeast transformants.
Real‑time quantitative (RT‑PCR)
Total RNA was extracted from a series of engineered S. 
cerevisiae mutant strains using GenElute™ mRNA Mini-
prep Kit (Sigma-Aldrich, USA) according to the manu-
facturer’s protocol. The yield of RNA was determined 
using a NanoDrop 2000 spectrophotometer (Thermo Sci-
entific, USA), and the integrity was evaluated using aga-
rose gel electrophoresis stained with ethidium bromide. 
Complementary DNA (cDNA) was generated by Prim-
erScript RT Enzyme Mix I (TaKaRa, Japan). 0.5 μg RNA 
was used as template and oligo (dT) was used as a primer. 
The cDNA was then diluted ten times in nuclease-free 
water and stored at −20 °C.
Real-time PCR was performed using LightCycler® 
480 Real-time PCR Instrument (Roche, Switserland); 
2  ×  LightCycler® 480 SYBR Green I Master (Roche, 
Swiss) was used as a PCR reagent. The primer sequences 
listed in Table  3 were designed in the laboratory and 
synthesized by Generay Biotech (Generay, PRC) based 
on the mRNA sequences obtained from the NCBI data-
base. The expression levels of mRNAs were normalized 
to actin gene ACT1 and were calculated using the 2−ΔΔCt 
method [39].
Measurement of yeast growth
The growth rate of yeast cells were determined by meas-
uring OD660 after appropriate dilutions using a spectro-
photometer (Ultrospec 2100 Pro, GE healthcare, Fairfield, 
USA) every 8 h. The measurements were continued until 
the OD660 nm reached the plateau. This experiment was 
repeated 3 times. The growth curve of different strains 
was drawn by software of Excel Microsoft Office Profes-
sional Plus 2013 (Microsoft, Redmond, USA).
Extraction of intracellular carboxypeptidase Y
The cells were collected by centrifugation (10,000×g, 
1 min) and then incubated in 1 ml lyticase buffer (1.0 M 
sorbitol, 2 mM MgCl2, 0.14 % β-mercaptoethanol, 50 mM 
Tris–HCl, pH 7.5) with lyticase (Sigma-Aldrich, Shang-
hai, China) at a concentration of 50 U/OD600. After incu-
bation (30  °C, 60 min) most of the cells were converted 
to spheroplasts. The spheroplasts were collected and 
washed twice with ice-cold lysis buffer (0.2  M sorbitol, 
1  mM EDTA, 50  mM Tris–HCl, pH 7.5). Spheroplasts 
were then suspended in 500  μl lysis buffer contain-
ing protease inhibitors (1  mM PMSF) and an appropri-
ate amount of glass beads. The mixture was incubated 
on ice for 30 s and vortexed 30 s for about five to seven 
Table 2 Plasmids and S. cerevisiae strains used in this study
Description Source
Plasmid
pY26TEF‑GPD (pY26) URA3/2μ yeast shuttle vector containing GPD1 promoter [37]
pY26‑RHO1 RHO1 expressed from GPD1 promoter in pY26TEF‑GPD This study
pY26‑FKS2 FKS2 expressed from GPD1 promoter in pY26TEF‑GPD This study
pRS424TEF TRP1/2μ yeast shuttle vector containing TEF1 promoter [38]
pRS424TEF‑LYZ hLYZ expressed from TEF1 promoter in pRS424TEF This study
pRS424TEF‑LYZ(R59S) hLYZ(R59S) expressed from TEF1 promoter in pRS424TEF This study
Strains
W303A‑pY26 As in W303‑1A and blank pY26TEF‑GPD This study
W303A‑RHO1 As in W303‑1A and pY26‑RHO1 This study
W303A‑FKS2 As in W303‑1A and pY26‑FKS2 This study
Δalg3Δoch1‑RHO1 As in Δalg3Δoch1 and pY26‑RHO1 This study
Δalg3Δoch1‑FKS2 As in Δalg3Δoch1 and pY26‑FKS2 This study
Δalg3Δoch1‑pY26 As in Δalg3Δoch1 and blank pY26TEF‑GPD This study
Δalg3Δoch1‑LYZ As in Δalg3Δoch1 and pRS424TEF‑LYZ This study
W303A‑pY26‑LYZ(R59S) As in W303A with blank pY26TEF‑GPD and pRS424TEF‑LYZ (R59S) This study
Δalg3Δoch1‑LYZ(R59S) As in Δalg3Δoch1 and pRS424TEF‑LYZ (R59S) This study
Δalg3Δoch1‑pY26‑LYZ (R59S) As in Δalg3Δoch1 with pRS424TEF‑LYZ (R59S) and blank pY26TEF‑GPD This study
Δalg3Δoch1‑RHO1‑LYZ (R59S) As in Δalg3Δoch1 with pRS424TEF‑LYZ (R59S) and pY26‑RHO1 This study
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cycles (URBomix VORTEX-GENIE, Scientific Industries, 
USA). Cells were lysed and centrifuged (1000×g, 4 °C) for 
10 min to remove unlysed cells and cell wall debris. The 
suspensions were carefully collected as whole intracel-
lular protein. Protein concentration was determined by 
a bicinchoninic acid (BCA) protein assay kit (Beyotime, 
Jiangsu, China). About 10 μg of protein was separated via 
SDS-PAGE for western blotting with anti-CPY antibody 
(Thermo Scientific, Waltham, USA) as described below.
Detection of secreted human lysozyme
The culture media was collected by centrifugation 
(1000×g, 10  min) and the cell pellet was removed. The 
spent media was then centrifuged (4000×g, 4 °C) with an 
Amicon-Ultra Centrifugal Filter (molecular weight cut 
off 10 kD, Millipore, Shanghai, China) and concentrated 
into 250  μl. Protein concentrations were determined as 
above. About 10  μg of protein was separated via SDS-
PAGE and human lysozyme was detected by western 
blotting with anti-FLAG antibody (Transgen, Beijing, 
China) as described below. This experiment was repeated 
3 times.
Western blot analysis
Proteins were suspended in sample buffer (2 % SDS, 5 % 
glycerol, 5  % 2-mercaptoethanol, 0.002  % bromophe-
nol blue, 62.5  mM Tris–HCl, pH 6.8) and incubated in 
100 °C for 3 min. Proteins were separated in 10 or 12 % 
SDS–polyacrylamide gels and blotted onto PVDF mem-
branes. For blocking Tris-buffered saline containing 0.5 % 
Tween 20 (TBST) and 5  % dry milk (Trans-Blot Turbo 
system, Biorad, USA) was used. The appropriate primary 
antibodies were diluted in TBST and 5  % dry milk fol-
lowed by incubation with secondary antibodies. Signals 
were visualized by Clarity Western ECL Substrate (Bio-
Rad, Shanghai, China) and images were obtained using 
ImageQuant LAS 4000 mini (GE Healthcare Bio-Science, 
Stockholm, Sweden).
Quantitative measurements of β‑glucan
The amount of β-glucan per gram cells were measured 
using aniline blue as described previously with some 
modifications [40, 41]. Cells were grown to early log 
phase (2.5 × 106 cells) and harvested (10,000×g, 1 min). 
The cells were washed twice with 1 ml TE buffer (10 mM 
Tris–HCl, 1 mM EDTA, pH = 8.0), resuspended to 250 μl 
in TE and then 6 M NaOH was added to a final concen-
tration of 1  M. Following incubation in a water bath at 
80 °C for 30 min, 1.05 ml of AB mix [0.03 % aniline blue 
(Sigma-Aldrich, USA), 0.18 M HCl, and 0.49 M glycine/
NaOH, pH 9.5] was added. The tube was vortexed briefly 
and then incubated at 50 °C for 30 min. Fluorescence of 
β-glucan was quantified using a spectrofluorophotometer 
(Ultrospec 2100 Pro, GE healthcare, Fairfield, USA). Exci-
tation wavelength was 400 nm and emission wavelength 
was 460 nm. This experiment was repeated three times.
Transmission electron microscopy and light microscopy
Transmission electron microscopy (TEM) analysis of 
the S. cerevisiae cell wall was carried out as described 
by Bzducha-Wrobel et al. [42]. For microscopic observa-
tions, yeast cells in glutaraldehyde prepared in phosphate 
buffer (pH 7.2) were fixed in osmium solution (OsO4). 
After rinse with cold water and dehydration with etha-
nol, the samples were embedded in Epon resin. Ultrathin 
sections were prepared by means of an ultramicrotome 
(Leica UC6, Biberach, Germany). Thereafter, the sections 
were stained as described by Deryabina et  al. [43] and 
examined by TEM (Hitachi HT7700, Ibaraki, Japan).
Light microscopic images were obtained using a Nikon 
Eclipse Ti-E inverted microscope equipped with DS-Ri1 
camera and NIS-Element AR software (Nikon, Tokyo, 
Japan).
HPLC analysis of Asn‑linked oligosaccharides 
on mannoproteins
Cells were harvested (10,000×g, 1  min) and washed 
with deionized water three times and then centrifuged 
(5000×g, 4  °C, 10  min). Cells treated with 4  mL of 
100 mM citrate buffer (pH 7.0) per 1 g pellet, were then 
autoclaved (121 °C, 120 min). The supernatant was recov-
ered by centrifugation. Three volumes of cold ethanol 
were added to the supernatant, which was then kept on 
ice for 5  min. The pellet was recovered by centrifuga-
tion, dissolved again in water and freeze-dried (EYELA 
FD-1000 freeze dryer, Tokyo Rikakikai, Tokyo, Japan). To 
collect glycans, the pellet was treated with glycopepti-
dase F (Takara, Dalian, China) and pyridylamination was 
carried out using a commercially available reagent kit 
(Takara, Dalian, China). Pyridylaminated oligosaccha-
rides were analyzed by HPLC using a size-fractionation 
column (TSKgel Amide-80, TOSOH, Japan) [44].
Table 3 Primers and amplification product sizes for each gene in quantitative real-time RT-qPCR analysis
Gene Forward primer Reverse primer Product length(bp)
RHO1 GAATGTTCGGCCAAGACTG CTTCTTAGCTTTACCATTCGTT 102
FKS2 GGTGGTCGTATCAAGCAT CCATACCAGCACCGATCTTA 103
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